Lazard Capital Starts Vanda Pharmaceuticals (VNDA) at Buy
Tweet Send to a FriendGet Alerts VNDA Hot Sheet
Price: $6.58 +19.64%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Trade VNDA Now!
Lazard Capital initiates coverage on Vanda Pharmaceuticals (NASDAQ: VNDA) with a Buy. PT $11.00.
For an analyst ratings summary and ratings history on Vanda Pharmaceuticals click here. For more ratings news on Vanda Pharmaceuticals click here.
Shares of Vanda Pharmaceuticals closed at $3.91 yesterday, with a 52 week range of $2.92-$5.47.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Vanda Pharmaceuticals click here. For more ratings news on Vanda Pharmaceuticals click here.
Shares of Vanda Pharmaceuticals closed at $3.91 yesterday, with a 52 week range of $2.92-$5.47.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
- BofA/Merrill Lynch Starts Dangdang (DANG) at Buy
- First Analysis Starts Digi International (DGII) at Equal Weight
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Lazard
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
